Effect of vaccine dose on severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antibody levels in a vaccinated community in Gowa Regency, Indonesia

Effect of vaccine dose on severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antibody levels in a vaccinated community in Gowa Regency, Indonesia

BACKGROUND: The administration of the coronavirus disease 2019 (COVID-19) vaccine aims to stimulate the production of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antibodies. This leads to an enhanced production of neutralizing antibodies (Nabs), which naturally neutralize the virus...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Andi Magfirah Hamsi, Ridwan Amiruddin, A. Arsunan Arsin, Andi Zulkifli Abdullah, Hasnawati Amqam, Shanti Riskiyani
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: Wolters Kluwer Medknow Publications 2024-02-01
Sarja:Journal of Education and Health Promotion
Aiheet:
comorbidities
covid-19 infection
sars-cov-2 antibody levels
vaccine dose
vitamin consumption
Linkit:https://journals.lww.com/10.4103/jehp.jehp_886_23

Internet

https://journals.lww.com/10.4103/jehp.jehp_886_23

Samankaltaisia teoksia